Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

MMereo BioPharma Group plc

EconomyAI buildoutMarket MapFundsWatchlist
Log in
M

Mereo BioPharma Group plc

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

Loading earnings…

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
YearRevenue YoYGross marginCash & equivalents
YearRevenue YoYGross marginCash & equivalents
(Filed on March 19, 2026)
—73.4%$41M

An annual SEC report is unavailable for this year.

(Filed on March 19, 2026)
-100.0%—$69.8M
(Filed on March 26, 2025)
—74.3%$57.4M
(Filed on March 27, 2024)
-100.0%—$68.2M
(Filed on March 28, 2023)
—50.9%$127.1M
(Filed on March 28, 2023)
——$31.9M
(Filed on March 31, 2022)
——$21.5M
(Filed on March 31, 2021)
——$31.8M
(Filed on June 15, 2020)
——$67.4M
(Filed on May 29, 2019)
———